1. Process of payment to suppliers after acceptance of goods

a. In accordance with the provisions of section VI: Payment Management of the bidding conditions of the consolidated purchase 2021, "UNOPS will make the payment for each delivery of goods as follows: one hundred percent (100%) within a period 45 days after receiving the goods and following the procedure described below:
i. Accreditation of documentation to conformity;
ii. Commercial invoice;
iii. Acceptance of the good by the competent authority. "
b. UNOPS is executing payments according to the procedure defined in the bidding conditions and it is working together with INSABI to speed up the acceptance times of goods by the competent authority.
c. Regarding the UNOPS 2022 consolidated purchase, the payment process is stipulated in section VII: Payment Management of the bidding conditions for the 2022 consolidated purchase: "UNOPS undertakes to make the payment of one hundred percent (100%) of the price of the goods accepted by the Institute of Health for Well-being (INSABI), within forty-five (45) calendar days following the moment in which UNOPS receives (i) from INSABI, the acceptance of the goods from compliance with the Specific Agreement and its amendments; (ii) on behalf of the supplier, the documentation listed in the following paragraph:
i. Commercial invoice, and;
ii. Additional documentation that is requested according to the case.

2. Consolidated purchase UNOPS 2022

a. Considering that the UNOPS 2021 consolidated purchase covers a supply until the first half of 2022, the purchase that UNOPS will make corresponds to the second half of the year.
b. Regarding the tender launched by INSABI, in the information session it was reported that there are no duplications between the INSABI and UNOPS processes for 2022..

3. Long-term purchase agreements consolidated UNOPS 2021

a. The long-term agreements resulting from consolidated purchasing UNOPS 2021, they may be used to meet additional requirements to those covered by purchase orders in force, for which UNOPS would be requesting confirmation of the ability of the contractor to supply the required quantities.

4. 2022 consolidated purchase tender

a. How to access bidding information?
i. Tenders were issued on December 1st in the Mercado Global de las Naciones Unidas. To access all the information of the tender, request clarification and make a bid through the eSourcing system, providers must be registered (basic) in UNGM as providers of UNOPS. Support guidelines for enrollment in UNGM and how to respond to ads UNOPS in the eSourcing system found in the tender documents tab. other resources are additionally available as videos, FAQ and contact support the eSourcing system: eSourcing

b. Previous meetings or clarification
i. The preliminary or clarification meetings will be virtual. To participate, bidders must register in the links provided for each of the meetings (see tab "AD DETAILS", section "Details of the previous meeting or clarification") available in the tender published in UNGM. After registration they will receive a confirmation email with information to join the webinar.
ii. Verbal responses provided by UNOPS during pre-clearance or clarification meetings will not be binding. However, the minutes of the meetings will be shared with all participants via eSourcing and as such will form part of the bidding documents.

c. Tender clarifications
i. Requests for clarification can be sent from the date of publication of the call and until the deadline for clarification indicated in the "Information about the announcement / General information" tab. Requests for clarification can be submitted via the "Ad Information / Request Clarification" tab.

d. Presentation of offers
i. Offers must be submitted through the eSourcing platform according to what is indicated in the "Information about the announcement / General information" tab in UNGM.
e. Prequalification letter i. The prequalification letter was sent through the eSourcing system to each of the bidders who passed the "Evaluation of the qualification criteria", corresponding to the drug and / or healing material purchase processes of December 2020 (ITB / 2020 / 17938, ITB / 2020/17978, ITB / 2020/17979, ITB / 2020/18035 and / or ITB / 2020/18036).

f. Due diligence process
i. The due diligence and background verification process is carried out in accordance with the provisions of Section 8.10.2 of the Procurement Manual, Revision 7, which is available at: https://www.unops.org/es/business-opportunities/how-we-procure. That verification is carried out for each of the bidders who have reached the final evaluation stage and have an award recommendation, whether these are Mexican or foreign companies. With this process, UNOPS verifies the eligibility of suppliers under equal conditions, ensuring that contracts are only awarded to duly incorporated companies and without conflicts of interest.

g. Evaluation
i. The bid evaluation process is carried out entirely by UNOPS. This invitation to tender is carried out in accordance with the provisions described in Section I: Instructions to Bidders (available on the Documents tab) and the applicable provisions of the UNOPS Procurement Manual in effect at the time of publication (the latest version can be consulted at https://www.unops.org/es/business-opportunities/how-we-procure and the Organizational Directives and Administrative Instructions mentioned in the Procurement Manual.

5. Distribution and delivery of goods

a. The suppliers contracted by UNOPS deliver the goods to the central warehouses designated by INSABI. The distribution towards the end points corresponds to a process of internal coordination between INSABI and the institutions of the health sector.

b. Incidents in the distribution of goods:
i. Suppliers have the communication channels and tools implemented by UNOPS for reporting incidents during deliveries. These are managed with INSABI and the actions implemented are continuously monitored so that the goods are delivered in a timely manner.

6. UNOPS official communication channels

a. It is important to highlight that there are defined communication channels within each of the project processes.

b. The general public is reminded that UNOPS has the email mexico@unops.org davailable for any queries.

c. For specific inquiries to the project processes, the following communication channels can be used:
i. Bidding - Clarifications with bidders are managed directly through the esourcing system.
ii. For inquiries about deliveries, contracts and payments, the awarded suppliers have the communication channels in place to manage their inquiries. Questions that do not correspond to each area will not be answered by these channels.

d. Value added through the consolidated purchase UNOPS 2021 - market opening questions, value added questions UNOPS.

e. The objective through the consolidated purchase of UNOPS is to support the Mexican Government in the transformation of the public procurement system of the Health sector. This through:
i. Manage the timely supply of medicines and healing materials with quality products
ii. Promote transparency and prevent corruption through the adoption of practices in accordance with Fair and Equitable Public Management, with a view to expanding the market and achieving the best quality at the best price
iii. Generate savings and increase the performance of public funds through efficiencies in the procurement process

f. Regarding the above, it has been achieved:
i. The contracting of 878 million pieces for 1,050 keys for medicines and healing materials, for a value of $ 2,226 million USD.
ii. Estimated savings of more than $ 500 million USD ($ 10,000 million) considering the maximum official reference price of the Government in previous purchases.
iii. Efficiency of public spending through the 33% improvement in generic prices and 10% in patents, in relation to previous purchases.
iv. Market deconcentration - in the joint purchase of INSABI and UNOPS 2021, 97 suppliers account for 80% of drug spending, compared to 18 suppliers in 2018.
v. Market opening - suppliers from 7 different countries are part of the UNOPS purchase..

7. Health registrations and patents

a. Will the sanitary registrations submitted in the 2021 process be accepted by 2022, or will new registration processes have to be carried out?
i. The health records issued by COFEPRIS and authorized under any modality, are valid for the presentation of offers, as long as they meet the evaluation criteria of the purchase process for the 2022 supply.
ii. The new sanitary registration application procedures that are covered by the recognition agreements related to the Mexican regulation and presented for the 2021 process, or prior to this and that have not yet received a definitive response from COFEPRIS, may be submitted during the period for submitting offers in the 2022 purchase process, as long as they meet the process evaluation criteria.
iii. According to what is established in the bidding documents, for the offers presented under the modality "Medicines WITHOUT Health Registration or Marketing Authorization issued by COFEPRIS that have a Health Registration or Marketing Authorization issued by Regulatory Agencies or Prequalification with recognition of equivalence", The Sanitary Registry issued by COFEPRIS will not be required for the presentation of the offer, however, it is necessary for the conclusion of the contract.

b. How does UNOPS ensure non-infringement of patents?
i. UNOPS is fully committed to respecting industrial property rights, both those included in local laws and those established by international trade treaties. Consequently, UNOPS in its bidding rules asked the bidders to fill out form G "Declaration of technical compliance of the drug" in which the bidder declares under protest of being truthful that "My client has carried out the corresponding verifications and certifies that the drug offered does not cause an infringement of intellectual property rights in accordance with the provisions of the Federal Law for the Protection of Industrial Property ". Additionally, UNOPS will only sign a contract with bidders who achieve approval of the sanitary registry by COFEPRIS, as a result, and in accordance with the responsibilities of Mexican institutions established in the Mexican regulatory framework, COFEPRIS in its review, may consult to the IMPI on the product to authorize and confirm that there is no infringement of patents in accordance with the Federal Law for the Protection of Industrial Property.